source
- Lilly data point to ‘maintenance’ strategies for GLP-1 weight lossA pair of trial results published in medical journals suggest switching from high-dose injectables to lower doses or pills could help people with obesity keep their weight down over the long term.BioPharma Dive · 2mo ago↗ source
- Post-Hoc: Why FDA Commissioner Marty Makary was oustedMarty Makary never stood a chance. Over the last few days, the now-former FDA commissioner had been left to twist in the wind, after headlines emerged late last week that President Donald Trump had…Endpoints · 2mo ago↗ source
- Assertio accepts new buyout bid; AI biotech Isomorphic banks $2BAssertio’s latest offer represents a roughly 31% premium over an initial acquisition proposal. Elsewhere, Kyverna is readying a first-of-its-kind approval application and AC Immune is swapping CEOs.